Three years after raising $100 million in series A funds, the Atlas Venture-backed biotech has chosen a lead drug candidate.
Researchers at the University of Missouri found that diet and exercise can significantly improve liver disease caused by too ...
Verywell Health on MSN5d
How Liver Fibrosis Develops and Is TreatedLiver fibrosis causes scar tissue to form on the liver, sometimes leading to chronic liver disease. Learn about noninvasive ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced new research to be presented at The Liver Meeting® 2024, hosted by the ...
News Medical on MSN2d
Liver function discovery could revolutionize treatments for cardiovascular diseaseA new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...
Medical Xpress on MSN13d
New research offers hope for treating metabolic dysfunction-associated liver diseaseMetabolic dysfunction-associated steatotic liver disease (MASLD) — previously known as "non-alcoholic fatty liver disease" — ...
A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...
Blocking the enzyme ACMSD can significantly reduce damage caused by metabolic liver disease according to a new study.
Last week, BioVie announced a significant milestone: a Notice of Allowance from the Japan Patent Office for its application regarding a novel liquid formulation of terlipressin. This formulation, ...
A new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of liver cancer that ...
By Dr. Joseph Kim University of Kentucky Liver cancer is the sixth leading cause cancer death in the U.S. The most common ...
A group of researchers at VCU Massey Comprehensive Cancer Center was awarded $13 million by the National Cancer Institute.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback